Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Johann S. de Bono, Ursula Vogl et al.|Nature|2023Cited by 119
Advanced Prostate Cancer with ATM Loss: PARP and ATR InhibitorsAntje Neeb, Johann S. de Bono, Nicolás Herranz et al.|European Urology|2020Cited by 118
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate CancerAdam Sharp, Johann S. de Bono, Jon Welti et al.|European Urology|2019Cited by 83